Stents Vs. Balloons Question For Peripheral Artery Disease Gets Attention At Veith
This article was originally published in The Gray Sheet
Executive Summary
The presence of the first drug-eluting stent on the U.S. market to treat peripheral artery disease is certainly not the end of the discussion for how peripheral artery patients will be treated, clinicians made clear at the influential Veith Symposium this month.